In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of Caredx Inc (NASDAQ: CDNA) closed at $19.11 in the last session, up 1.22% from day before closing price of $18.88. In other words, the price has increased by $1.22 from its previous closing price. On the day, 0.61 million shares were traded.
Ratios:
We take a closer look at CDNA’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.61 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 52.81. For the most recent quarter (mrq), Quick Ratio is recorded 3.84 and its Current Ratio is at 4.11. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on January 15, 2025, Upgraded its rating to Equal Weight and sets its target price to $24 from $28 previously.
On August 28, 2024, Wells Fargo started tracking the stock assigning a Underweight rating and target price of $28.
BTIG Research Upgraded its Neutral to Buy on August 19, 2024, while the target price for the stock was maintained at $40.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 18 ’25 when Valantine Hannah sold 10,570 shares for $19.16 per share. The transaction valued at 202,566 led to the insider holds 38,994 shares of the business.
Maag Peter sold 10,000 shares of CDNA for $192,420 on Jun 17 ’25. The Director now owns 318,846 shares after completing the transaction at $19.24 per share. On Jun 18 ’25, another insider, HANNAH VALANTINE, who serves as the Director of the company, bought 10,570 shares for $19.52 each.
Valuation Measures:
As of this moment, Caredx’s Price-to-Earnings (P/E) ratio for their current fiscal year is 16.59, and their Forward P/E ratio for the next fiscal year is 115.82. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.07 while its Price-to-Book (P/B) ratio in mrq is 2.79.
Stock Price History:
Over the past 52 weeks, CDNA has reached a high of $34.84, while it has fallen to a 52-week low of $13.81. The 50-Day Moving Average of the stock is 8.35%, while the 200-Day Moving Average is calculated to be -12.88%.
Shares Statistics:
A total of 55.46M shares are outstanding, with a floating share count of 51.90M. Insiders hold about 6.78% of the company’s shares, while institutions hold 98.60% stake in the company.
